Acute ST-elevation myocardial infarction in young patients: 15 years of experience in a single center

Su-Kiat Chua1, Huei-Fong Hung, Kou-Gi Shyu

  • 1Division of Cardiology, Department of Internal Medicine, Shin Kong Wu Ho-Su Memorial Hospital, No. 95 Wen Chang Road, Taipei, Taiwan.

Clinical Cardiology
|March 18, 2010
PubMed

Insights

Young patients with ST-elevation myocardial infarction (STEMI) exhibit distinct risk factors like smoking and obesity, but experience better outcomes than older patients. Modifiable factors are key for managing STEMI in younger individuals.

Area of Science:

  • Cardiology
  • Internal Medicine
  • Public Health

Background:

  • Limited research exists on young patients experiencing ST-elevation myocardial infarction (STEMI).
  • Understanding STEMI in younger demographics is crucial for targeted prevention and treatment strategies.

Purpose of the Study:

  • To investigate the clinical characteristics and coronary angiographic features of young patients with STEMI.
  • To compare outcomes between young (< or =45 yrs) and older (>45 yrs) STEMI patients.

Main Methods:

  • Data from 849 consecutive STEMI patients (1992-2006) were analyzed.
  • Baseline clinical characteristics, coronary anatomy, and outcomes were compared between young and older patient groups.

Main Results:

  • Young STEMI patients (11.6%) were predominantly male, more likely to smoke, be obese, and have dyslipidemia.
  • Younger patients showed shorter hospital stays, less in-hospital morbidity and mortality, and significantly lower follow-up mortality.
  • Killip class III or IV predicted in-hospital outcomes in young STEMI patients; repeated PCI and reinfarction rates were similar between groups.

Conclusions:

  • Smoking, obesity, and dyslipidemia are key modifiable risk factors for STEMI in young patients.
  • Young STEMI patients demonstrate better outcomes than older counterparts, with comparable rates of repeat PCI and reinfarction.
  • Killip class III or IV is a significant predictor of in-hospital morbidity and mortality in young STEMI patients.
Abstract

Related Concept Videos

Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations01:19

Acute Coronary Syndrome II: Pathophysiology and Clinical Manifestations

The pathophysiology of Acute Coronary Syndrome [ACD] involves several key processes:The main underlying cause of ACD is atherosclerosis, a chronic inflammatory disease characterized by the buildup of lipid-laden plaques within the coronary arteries.As the atherosclerotic plaque grows in the coronary artery, it may become unstable due to the formation of a lipid-rich core and a thin fibrous cap. Inflammatory cells within the plaque, such as macrophages, secrete enzymes that degrade the...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
Myocarditis III: Medical Management01:14

Myocarditis III: Medical Management

Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Myocarditis II: Clinical Features and Diagnostic Tests01:27

Myocarditis II: Clinical Features and Diagnostic Tests

Myocarditis is an inflammation of the heart muscle. The symptoms vary widely, encompassing asymptomatic presentations to severe, acute manifestations.Clinical PresentationAsymptomatic cases: In some instances, myocarditis may be asymptomatic, with the infection resolving without intervention. These cases often go undetected unless discovered incidentally through diagnostic imaging or tests conducted for other reasons.General Early Symptoms: Early symptoms of myocarditis are non-specific and can...